Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains

1994

Bales, 2000, Neuroinflammation and Alzheimer's disease: critical roles for cytokine/A beta-induced glial activation, NF-kappaB, and apolipoprotein E, Neurobiol Aging, 21, 427, 10.1016/S0197-4580(00)00143-3

Bonafé, 1999, p53 variants predisposing to cancer are present in healthy centenarians, Am J Hum Genet, 64, 292, 10.1086/302196

Bonafé, 2004, The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death, Cell Death Differ, 11, 962, 10.1038/sj.cdd.4401415

Cardozo, 2002, Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a non-processive pathway, Arch Biochem Biophys, 408, 103, 10.1016/S0003-9861(02)00493-9

Caruso, 2003, Genetics of neurodegenerative disorders, N Engl J Med, 349, 193, 10.1056/NEJM200307103490219

Checler, 2000, Role of the proteasome in Alzheimer's disease, Biochim Biophys Acta, 502, 133, 10.1016/S0925-4439(00)00039-9

Chomezynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction, Anal Biochem, 162, 156

Chomezynski, 1993, A reagent for the single step simultaneous isolation of RNA, DNA and protein from cell and tissue samples, Biotechniques, 15, 532

Diaz-Hernández, 2003, Neuronal induction of the immunoproteasome in huntington's disease, J Neurosci, 23, 11653, 10.1523/JNEUROSCI.23-37-11653.2003

Ding, 2003, Characterization of chronic low-level proteasome inhibition on neural homeostasis, J Neurochem, 86, 489, 10.1046/j.1471-4159.2003.01885.x

Ding, 2003, Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress, FEBS Lett, 546, 228, 10.1016/S0014-5793(03)00582-9

Floyd, 2002, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases, Neurobiol Aging, 23, 795, 10.1016/S0197-4580(02)00019-2

Foster, 2002, Induced neuronal expression of class I major histocompatibility complex mRNA in acute and chronic inflammation models, J Neuroimmunol, 131, 83, 10.1016/S0165-5728(02)00258-8

Franceschi, 2000, Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space, Vaccine, 18, 1717, 10.1016/S0264-410X(99)00513-7

Früh, 1994, Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex, EMBO J, 13, 3236, 10.1002/j.1460-2075.1994.tb06625.x

Gray, 2003, Ubiquitin, proteasomes, and the aging brain, Sci Aging Knowledge Environ, 2003, RE6, 10.1126/sageke.2003.34.re6

Gregori, 1995, Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro, J Biol Chem, 270, 19702, 10.1074/jbc.270.34.19702

Heward, 1999, Association of the large multifunctional proteasome (LMP2) gene with Graves’ disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501, Clin Endocrinol, 51, 115, 10.1046/j.1365-2265.1999.00755.x

Husom, 2004, Altered proteasome function and subunit composition in aged muscle, Arch Biochem Biophys, 421, 67, 10.1016/j.abb.2003.10.010

Keck, 2003, Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease, J Neurochem, 85, 115, 10.1046/j.1471-4159.2003.01642.x

Keller, 2000, Impaired proteasome function in Alzheimer's disease, J Neurochem, 75, 436, 10.1046/j.1471-4159.2000.0750436.x

Keller, 2002, The proteasome in brain aging, Ageing Res Rev, 1, 279, 10.1016/S1568-1637(01)00006-X

Kesmir, 2002, Prediction of proteasome cleavage motifs by neural networks, Protein Eng, 15, 287, 10.1093/protein/15.4.287

Khachaturian, 1985, Diagnosis of Alzheimer's disease, Arch Neurol, 42, 1097, 10.1001/archneur.1985.04060100083029

Kloetzel, 2001, Antigen processing by the proteasome, Nat Rev, 2, 179, 10.1038/35056572

Lam, 2000, Inhibition of the ubiquitin-proteasome system in Alzheimer's disease, Proc Natl Acad Sci USA, 97, 9902, 10.1073/pnas.170173897

Lee, 2000, Gene-expression profile of the ageing brain in mice, Nat Genet, 25, 294, 10.1038/77046

Licastro, 2003, Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain, Neurobiol Aging, 24, 921, 10.1016/S0197-4580(03)00013-7

Maksymowych, 2000, LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis, J Rheumatol, 27, 183

McGeer, 2002, Local neuroinflammation and the progression of Alzheimer's disease, J Neurovirol, 8, 529, 10.1080/13550280290100969

Meiners, 2003, Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes, J Biol Chem, 278, 21517, 10.1074/jbc.M301032200

Mishto, 2002, Age dependent impact of LMP polymorphisms on TNF alpha-induced apoptosis in human peripheral blood mononuclear cells, Exp Gerontol, 37, 301, 10.1016/S0531-5565(01)00196-6

Mishto, 2003, Immunoproteasomes and immunosenescence, ARR, 2, 419

Neumann, 1995, Induction of MHC class I genes in neurons, Science, 269, 549, 10.1126/science.7624779

Noda, 2000, Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats, Biochem Biophys Res Commun, 277, 348, 10.1006/bbrc.2000.3676

Piccinini, 2003, Interferon-gamma-inducible subunits are incorporated in human brain 20S proteasome, J Neuroimmunol, 135, 135, 10.1016/S0165-5728(02)00439-3

Preece, 2003, Quantifying mRNA in post-mortem human brain: influence of gender, age at death, post-mortem interval, brain pH, agonal state and inter-lobe mRNA variance, Mol Brain Res, 118, 60, 10.1016/S0169-328X(03)00337-1

Rock, 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules, Cell, 78, 761, 10.1016/S0092-8674(94)90462-6

Rock, 1999, Degradation of cell proteins and the generation of MHC class I-presented peptides, Annu Rev Immunol, 17, 739, 10.1146/annurev.immunol.17.1.739

Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2

Sorbi, 1994, ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease, Neurosci Lett, 177, 100, 10.1016/0304-3940(94)90054-X

Sullivan, 2004, Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover, J Biol Chem, 279, 20699, 10.1074/jbc.M313579200

The Dementia Study Group of the Italian Neurological Society, Guidelines for the diagnosis of dementia and Alzheimer's disease. Neurol Sci 2000;21(4):187–194.

Vinasco, 1998, Analysis of LMP and TAP polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in rheumatoid arthritis, Ann Rheum Dis, 57, 33, 10.1136/ard.57.1.33

Voges, 1999, The 26S proteasome: a molecular machine designed for controlled proteolysis, Annu Rev Biochem, 68, 1015, 10.1146/annurev.biochem.68.1.1015

Zanelli, 1993, Genomic organization and tissue expression of the mouse proteasome gene Lmp-7, Immunogenetics, 38, 400, 10.1007/BF00184520

Zhao, 2003, The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain, Neurochem Res, 28, 307, 10.1023/A:1022337519035

Zhou, 1993, Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (LMP-2), Proc Nat Acad Sci USA, 90, 2681, 10.1073/pnas.90.7.2681

Zhou, 1993, Genomic organization and tissue expression of mouse proteasome gene Lmp-2, Genomics, 16, 664, 10.1006/geno.1993.1245